Medicus Sciences Acquisition Corp.

Medicus Sciences Acquisition Corp. (Nasdaq: MSAC) is a blank-check company formed to pursue an acquisition in the healthcare and life sciences sector. The company filed an S-1/A amendment with the SEC on January 28, 2021, reflecting updates to its initial registration statement as part of the IPO process, with the offering completed in early 2021. The SPAC targets businesses operating across medical technology, therapeutics, diagnostics, and related life sciences verticals. MSAC represents one of numerous healthcare-focused SPACs that came to market during the record 2021 blank-check boom. Visit SpacDesk and sign up for full data on MSAC, including filing history, deal status, and comparable transactions across the healthcare SPAC universe.